Father with 10 brain tumours refused cancer drug has 33,000 cost of treatment met by total stranger


Pin It

Father with 10 brain tumours refused cancer drug has 33,000 treatment paid for by total stranger
Property developer to pay for medication that South Tyneside Primary Care Trust said was too expensive'I never thought for one minute there would be people in the world as generous as this,' says patient's mother

Enlarge

 Glen Cunningham, partner Yasmin Malik, and baby son Glen, 10 months

New hope: Glen Cunningham, with partner Yasmin Malik and son Glen, can hardly believe that a total stranger has agreed to pay for him to receive a life-prolonging drug

The family of a man with 10 brain tumours say their prayers have been answered after a generous stranger agreed to pay for a life-prolonging drug denied to him by the NHS.

Father-of-two Glen Cunningham, 29, who suffers from a rare form of cancer called gliosarcoma, had been planning a fundraising mission after he was refused Avastin, a ‘wonder-drug’ which costs 33,500 per year.

But he now hopes to spend more time with his partner and young children after a property developer decided to donate the entire sum himself.

Kenny Vickers, 34, and wife Melody, 33, whose youngest son is fighting for life after being born prematurely, were touched by a report of Mr Cunningham's plight in a local newspaper.

Mr Cunningham's mother Patricia, 64, from South Shields, Tyne and Wear, said: 'I misheard the amount, I thought it was
3,500, which in itself is fantastic, but 33,500 I am going to cry.

'What can we say except our prayers have been answered.'

Speaking after Mr Cunningham and his family travelled to Sheffield for more treatment, his partner Yasmin Malik, 26, said: 'I am honestly stunned.

'I don’t quite know what to say. I
never thought for one minute there would be people in the world as
generous as this, it’s not sinking in.

'Glen is still half asleep from
yesterday, I don’t think he can believe it, we can’t thank this man
enough for what he has done.'

Mr Cunningham, a plasterer from South Shields, Tyne and Wear, hopes the drug will shrink his tumours, two of which are inoperable, and extend his life, giving him more time to spend with daughter Lauren, seven, and a 10-month-old son, also named Glen.

South Tyneside Primary Care Trust (PCT) had
said there wasn’t enough evidence the injections, which are licensed by
the Government, would help him.

Mr Vickers, of the Isle of Skye, also has a home in South Shields and read of Mr Cunningham's predicament in their local newspaper, the Shields Gazette.

He said he and his wife were in 'floods of tears' at Mr Cunningham's circumstances.

'We are lucky enough to be quite
comfortable financially and so we would like to give Glen the chance to
see his children grow up and spend more time with them,' he added.

'To me life is everything and very precious, and I want to give Glen the quality time he deserves with his family.'

But Mr Vickers, a father of seven, is also facing a troubled time in his own family.

His youngest child, 10-week-old
Preston, is fighting for life after being born 14 weeks prematurely,
weighing just 1lbs 11.5 ozs and is in South Tyneside District Hospital’s
Special Care Baby Unit.

Preston has suffered from two holes in
his bowel, plus a double hernia and needs further surgery at
Newcastle’s Royal Victoria Infirmary on Thursday.

Mr Vickers said: 'We have children and we
know how difficult it can be, especially at the moment, so we know what
it’s like to be going through hard times.

'We wish Glen and his family the best
of luck and we just hope our gift will help.

'If he needs anything else,
all he has to do is ask.'

Glen, 29, with his ten-month old son from South Shields. He needs to raise more than 33,000 for a year's drug treatment

Doting father: Mr Cunningham hopes the injections will enable him to spend more time with his son, Glen, and daughter, Lauren

South Tyneside PCT told Mr Cunningham last week that it was not prepared to pay the 33,600 a year it would cost for him to receive a course of twice-monthly injections.

He then began planning a fundraising campaign, claiming it was his 'last chance', but Mr Vickers's intervention means he can be treated even sooner.

Mr Cunningham was diagnosed with cancer in December 2006 after he suffered a seizure.

During 2007 he endured chemotherapy, radiotherapy and surgery, and was delighted when he went into remission.

Three years later, in September 2010, doctors discovered the tumour had returned and Glen found himself facing further surgery.

When the cancer came back yet again at
the start of 2011, Mr Cunningham went through gamma knife – a special
type of brain radiation treatment.

The difficulties surrounding the drug Avastin relate in part to the fact that, while it can be legally prescribed in the UK,

it has not been approved for use by
the National Institute for Health and Clinical Excellence (NICE) – which
gives advice on which drugs should be made available to the NHS.

NICE, which weighs up the relative
costs and benefits of drugs, believes Avastin is too expensive based on
the benefits it provides.

From 2014, the Department of Health plan to bring in a new system called 'value-based pricing.'

Under the plans, groups of GPs will decided whether a drug should be funded or not rather than the medicines watchdog NICE.

Ministers hope this will help to make new drugs affordable through direct price negotiations with pharmaceutical companies.

NICE will continue to give advice on which drugs are effective.